Effects of an Adaptogenic Extract on Electrical Activity of the Brain in Elderly Subjects With Cognitive Impairment

Clinical trial NCT03780621 · COMPLETED

Trial details

NCT number: NCT03780621
Sponsor: EuroPharma, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Cognitive Impairment, Mild

Start date: 2019-04-01
Primary completion: 2019-06-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.